| Association of the NPAS3 gene and five other loci with response to the antipsychotic iloperidone identified in a whole genome association study C Lavedan, L Licamele, S Volpi, J Hamilton, C Heaton, K Mack, R Lannan, ... Molecular psychiatry 14 (8), 804-819, 2009 | 203 | 2009 |
| Tasimelteon for non-24-hour sleep–wake disorder in totally blind people (SET and RESET): two multicentre, randomised, double-masked, placebo-controlled phase 3 trials SW Lockley, MA Dressman, L Licamele, C Xiao, DM Fisher, ... The Lancet 386 (10005), 1754-1764, 2015 | 152 | 2015 |
| D-dupe: An interactive tool for entity resolution in social networks M Bilgic, L Licamele, L Getoor, B Shneiderman 2006 IEEE Symposium On Visual Analytics Science And Technology, 43-50, 2006 | 131 | 2006 |
| Whole genome association study identifies polymorphisms associated with QT prolongation during iloperidone treatment of schizophrenia S Volpi, C Heaton, K Mack, JB Hamilton, R Lannan, CD Wolfgang, ... Molecular psychiatry 14 (11), 1024-1031, 2009 | 128 | 2009 |
| Query-time entity resolution I Bhattacharya, L Getoor, L Licamele Proceedings of the 12th ACM SIGKDD international conference on Knowledge …, 2006 | 116 | 2006 |
| Common effect of antipsychotics on the biosynthesis and regulation of fatty acids and cholesterol supports a key role of lipid homeostasis in schizophrenia MH Polymeropoulos, L Licamele, S Volpi, K Mack, SN Mitkus, ED Carstea, ... Schizophrenia research 108 (1-3), 134-142, 2009 | 100 | 2009 |
| Interactive entity resolution in relational data: A visual analytic tool and its evaluation H Kang, L Getoor, B Shneiderman, M Bilgic, L Licamele IEEE transactions on visualization and computer graphics 14 (5), 999-1014, 2008 | 95 | 2008 |
| Applicability of a genetic signature for enhanced iloperidone efficacy in the treatment of schizophrenia. S Volpi, SG Potkin, AK Malhotra, L Licamele, C Lavedan Journal of Clinical Psychiatry 70 (6), 801, 2009 | 59 | 2009 |
| Treatment of circadian rhythm disorders MM Dressman, JJ Feeney, LW Licamele, MH Polymeropoulos US Patent 8,785,492, 2014 | 43 | 2014 |
| Delayed sleep phase disorder risk is associated with absenteeism and impaired functioning SMW Rajaratnam, L Licamele, G Birznieks Sleep Health 1 (2), 121-127, 2015 | 37 | 2015 |
| Social capital in friendship-event networks L Licamele, L Getoor Sixth International Conference on Data Mining (ICDM'06), 959-964, 2006 | 37 | 2006 |
| Treatment of circadian rhythm disorders MM Dressman, JJ Feeney, LW Licamele, MH Polymeropoulos US Patent 9,730,910, 2017 | 34 | 2017 |
| Treatment of circadian rhythm disorders MM Dressman, JJ Feeney, LW Licamele, MH Polymeropoulos US Patent 9,060,995, 2015 | 19 | 2015 |
| Predicting protein-protein interactions using relational features L Licamele, L Getoor | 18 | 2007 |
| Treatment of circadian rhythm disorders MM Dressman, LW Licamele, MH Polymeropoulos US Patent 9,549,913, 2017 | 16 | 2017 |
| RESET study demonstrates that tasimelteon maintains entrainment of melatonin and cortisol in totally blind individuals with non-24-hour circadian rhythms SW Lockley, MA Dressman, C Xiao, L Licamele, MH Polymeropoulos 95th Annual meeting of the endocrine society, Abstract SUN-137, 2013 | 16 | 2013 |
| Capital and benefit in social networks L Licamele, M Bilgic, L Getoor, N Roussopoulos Proceedings of the 3rd international workshop on Link discovery, 44-51, 2005 | 16 | 2005 |
| Tasimelteon treatment entrains the circadian clock and demonstrates a clinically meaningful benefit in totally blind individuals with non-24-hour circadian rhythms SW Lockley, MA Dressman, C Xiao, DM Fisher, R Torres, C Lavedan, ... 95th Annual meeting of the endocrine society, Abstract SUN-134 268, 2013 | 14 | 2013 |
| Treatment of circadian rhythm disorders MM Dressman, JJ Feeney, LW Licamele, MH Polymeropoulos US Patent 10,149,829, 2018 | 10 | 2018 |
| Antipsychotic treatment based on SNP genotype C Lavedan, S Volpi, L Licamele, MH Polymeropoulos US Patent 9,328,387, 2016 | 10 | 2016 |
Mihael H. PolymeropoulosCEO Vanda Pharmaceuticals, Professor Georgetown UniversityПідтверджена електронна адреса в vandapharma.com
